LOS ANGELES -- (BUSINESS WIRE) -- Targeted Medical Pharma (OTCQB: TRGM) is currently discussing the logistics of importing the company’s medical food products into China with a large Chinese pharmaceutical company. No assurances can be made that a definitive agreement will be consummated between the two companies at this time.
“Growth of international sales and distribution will contribute to the success of our 2014 fiscal initiatives,” said William Shell, M.D., Chief Executive Officer and Chief Science Officer at Targeted Medical Pharma. “Our discussions with a Chinese firm have been positive and informative, providing our company with a pathway to registration and distribution of our products in China.”
About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that develops medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and recently launched its first dietary supplement, Clearwayz™. The products are sold directly to physicians and pharmacies in the U.S. The company also is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells and pituitary hormones, including IGF-I.
This press release may contain forward-looking statements related to Targeted Medical Pharma’s business strategy, outlook, objectives, plans, intentions or goals. The words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Actual results could differ materially. Targeted Medical Pharma expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.